No credit card. No commitment.
5000+ G2 reviews
Arch Biopartners Inc (ARCH:TSXV) (ACHFF:OTCQB)
Biotechnology
Public company
Founded in 2010
Toronto, OntarioArch Biopartners Inc (ARCH:TSXV) (ACHFF:OTCQB)
BiotechnologyPublic companyFounded in 2010Toronto, Ontario
EmployeesArch Biopartners Inc (ARCH:TSXV) (ACHFF:OTCQB)'s financial review
Arch Biopartners Inc (ARCH:TSXV) (ACHFF:OTCQB)'s Revenue (Yearly)
37K
Employees
8
Total Funding
3.9M
Last Funding Round
500K
tsx
ACH
Arch Biopartners Inc (ARCH:TSXV) (ACHFF:OTCQB) information
Arch Biopartners is a biotechnology firm that focuses on the treatment of respiratory Pseudomonas aeruginosin infections.
Arch Biopartners Inc (ARCH:TSXV) (ACHFF:OTCQB) industries
Treating acute kidney injury
Treatments for inflammation
Sepsis
Acute organ inflammation
Arch Biopartners Inc (ARCH:TSXV) (ACHFF:OTCQB)'s financial review
Arch Biopartners Inc (ARCH:TSXV) (ACHFF:OTCQB)'s Revenue (Yearly)
37K
Employees
8
Total Funding
3.9M
Last Funding Round
500K
tsx
ACH
Employee Metrics
Technologies
Email Providers
Other
Hosting
Load Balancers
SSL Certificates
Captcha
Notable Alumni
Employees
Vice President Research And Development, Chief Scientific Officer
Co-Founder/ Partner
Creative Director, Director of Communications, Design, UX
Senior Project Manager
Prospect on LinkedIn
Find verified emails and direct dial mobile numbers of contacts on LinkedIn, and sync them with your CRM instantly
Download Extension
Why our clients choose Apollo
“Apollo completely changed the game for us. It allowed us to identify relevant targets that are ready to scale and reach out to them at the exact right time.”
Erik Straub
Head of Product, Kickfurther
“Using Apollo.io, we've solved the biggest problem for every business, the lead problem. We are now constrained by sales time and no longer lack interested prospects.”
Michael Transon
CEO, Victorious
